Atlas Trials

Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment

Clinical trial NCT00840125 · COMPLETED

Trial details

NCT number
NCT00840125
Sponsor
Meir Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2009-02-01
Primary completion
2010-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.